ARDS - Nursing Case Study

Pathophysiology

• Primary mechanism: Injury to the alveolar-capillary membrane, often due to inflammatory mediators, increases membrane permeability, leading to pulmonary edema. This impairs gas exchange, reducing oxygenation and causing severe hypoxemia.

• Secondary mechanism: Neutrophil activation and infiltration exacerbate inflammation, releasing proteases and reactive oxygen species, further damaging lung tissue and perpetuating the cycle of pulmonary edema and inflammation.

• Key complication: Loss of surfactant function due to protein-rich edema fluid leads to alveolar collapse (atelectasis), decreasing lung compliance and worsening respiratory failure.

Patient Profile

Demographics:

54-year-old female, retired chemical engineer

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Insulin, Amlodipine, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe shortness of breath and worsening hypoxemia

• Key symptoms: Acute respiratory distress, persistent cough, cyanosis, confusion, peripheral edema

• Vital signs: Temperature 101.3°F, Heart rate 130 bpm, Respiratory rate 34 breaths/min, Blood pressure 88/54 mmHg, SpO2 78% on 15 L/min non-rebreather mask

Section 1

As the healthcare team performs an initial assessment, they observe that the patient's condition is rapidly deteriorating. Her breath sounds are diminished bilaterally with diffuse crackles noted, suggesting widespread alveolar involvement. Despite being on a high-flow oxygen delivery system, her SpO2 remains critically low at 78%, and she exhibits signs of increased work of breathing, including the use of accessory muscles and nasal flaring. Her skin is cool and clammy, and she is notably confused, indicating possible cerebral hypoxia. Peripheral edema is more pronounced, particularly in the lower extremities, suggesting worsening fluid overload, which could compromise her respiratory status further.

Laboratory tests reveal a mixed acid-base disorder with a blood gas analysis showing metabolic acidosis (pH 7.28, HCO3- 18 mEq/L) and respiratory acidosis (PaCO2 60 mmHg), reflecting severe hypoventilation and impaired renal compensation due to her chronic kidney disease. The white blood cell count is elevated at 17,000/mm³, pointing towards an inflammatory or infectious process. Additionally, her BUN and creatinine levels are significantly increased (BUN 68 mg/dL, creatinine 3.8 mg/dL), confirming an acute kidney injury superimposed on her chronic kidney disease. The chest X-ray demonstrates bilateral infiltrates consistent with ARDS, and an echocardiogram shows no evidence of left ventricular dysfunction, effectively ruling out cardiogenic pulmonary edema.

Given the complexity of her condition and the risk of further complications, the healthcare team must prioritize interventions that address her respiratory failure while managing her hemodynamic instability and renal function. The decision to initiate mechanical ventilation is weighed against potential risks, such as barotrauma and ventilator-associated pneumonia, especially in the setting of her current infection risk. Simultaneously, strategies to optimize her fluid status and prevent further renal impairment are crucial, necessitating a delicate balance of diuretics and fluid resuscitation. The need for broad-spectrum antibiotics is considered to address potential underlying infections that could be exacerbating her ARDS. This situation demands meticulous clinical reasoning to navigate the multifaceted challenges presented by her critical condition.

Section 2

Change in Patient Status:

Shortly after the initiation of mechanical ventilation, the patient's condition begins to evolve. Her blood pressure, initially stable on a norepinephrine infusion, begins to fluctuate significantly, with readings dropping to 82/50 mmHg, raising concerns about potential septic shock or further exacerbation of her fluid imbalance. Her heart rate remains elevated at 128 beats per minute, and her temperature spikes to 38.5°C, suggesting an inflammatory response that could be secondary to an unresolved infectious process.

Despite the ventilatory support, her oxygenation remains suboptimal, with an SpO2 persistently hovering around 84%. The team notes a decrease in urine output to less than 20 mL/hour, further indicating worsening renal function and possible hypoperfusion. Repeat arterial blood gas analysis shows a slight improvement in pH to 7.30 but persistent hypercapnia with PaCO2 at 58 mmHg, underscoring the ongoing challenges in achieving adequate ventilation.

In light of these developments, the healthcare team must reevaluate their treatment strategy, considering the initiation of vasopressors to stabilize her hemodynamics and a potential escalation of renal support, possibly through continuous renal replacement therapy (CRRT). Additionally, the need to reassess her antimicrobial therapy is paramount, ensuring it is appropriately targeted given the possibility of an evolving infection, as indicated by her febrile response and leukocytosis. This critical juncture demands a thorough reassessment and collaborative decision-making to prevent further deterioration and guide the patient toward stabilization.

Section 3

As the team prepares for the potential initiation of continuous renal replacement therapy (CRRT), new diagnostic results reveal additional complexities. A repeat chest X-ray shows bilateral infiltrates consistent with worsening pulmonary edema and possible consolidation, raising concerns about the development of a superimposed bacterial pneumonia. The sputum culture, previously pending, now returns positive for Pseudomonas aeruginosa, prompting an urgent review of the current antimicrobial regimen. The medical team decides to broaden the antibiotic coverage to include high-dose intravenous piperacillin-tazobactam, ensuring it targets the resistant strain effectively.

Concurrently, a comprehensive metabolic panel reveals a significant electrolyte imbalance, with a serum potassium level dropping to 2.9 mEq/L and a magnesium level of 1.5 mg/dL. This hypokalemia and hypomagnesemia could further compromise cardiac function, especially in the context of her unstable hemodynamics and tachycardia. Electrolyte repletion protocols are initiated promptly to address these critical deficits. However, the patient's blood lactate level has risen to 4.5 mmol/L, indicating worsening tissue hypoxia and perfusion despite ongoing norepinephrine support. This prompts the team to increase the vasopressor dose cautiously, balancing the risk of aggravating her fluid imbalance.

As these findings are assimilated, the clinical picture becomes increasingly multifaceted. The medical team must now integrate these diagnostic insights with the patient's evolving condition, prioritizing interventions that stabilize her hemodynamics and address the underlying infectious process. The potential for additional complications such as cardiac arrhythmias or further respiratory compromise looms, necessitating heightened vigilance and interdisciplinary collaboration to navigate this critical phase. This stage of the patient's journey emphasizes the need for precise clinical judgment and adaptability in adjusting the treatment plan to mitigate risks and improve outcomes.

Section 4

As the patient's condition continues to evolve, the team closely monitors her response to the intensified interventions. Despite the broadened antibiotic coverage and electrolyte repletion efforts, her clinical status presents new challenges. Over the next 24 hours, the patient's respiratory function deteriorates further. Her oxygen saturation drops to 82% on high-flow nasal cannula, and she exhibits increasing work of breathing with the use of accessory muscles. Arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 55 mmHg, suggesting acute respiratory failure with mixed respiratory and metabolic acidosis. These findings necessitate urgent consideration for mechanical ventilation to ensure adequate oxygenation and carbon dioxide clearance.

In parallel, the team observes alarming changes in her cardiovascular status. Despite adjustments in vasopressor support, the patient's mean arterial pressure remains tenuous, fluctuating between 55-60 mmHg. A new onset of frequent premature ventricular contractions is noted on telemetry, raising concerns about impending arrhythmias. A repeat serum potassium level, despite supplementation, shows only marginal improvement at 3.2 mEq/L, and magnesium remains low at 1.6 mg/dL. These electrolyte imbalances, coupled with ongoing hemodynamic instability, heighten the risk for life-threatening cardiac events. The team deliberates on the need for additional antiarrhythmic support while contemplating the timing and potential risks of initiating CRRT to manage her fluid overload and prevent further electrolyte derangements.

Given the patient's precarious state, the interdisciplinary team convenes to reassess and refine the care plan. They prioritize stabilizing her respiratory and cardiovascular systems, recognizing that any deviation in clinical management could precipitate a rapid decline. The decision to transition to invasive mechanical ventilation is made, with plans to initiate CRRT once her hemodynamics are sufficiently stabilized. This plan underscores the necessity for synchronized, multi-disciplinary efforts to navigate her complex condition and optimize her chances for recovery, while maintaining readiness to address any new complications that may arise.

Section 5

As the team moves forward with the plan to initiate mechanical ventilation, they gather for a meticulous bedside assessment to ensure all parameters are optimal for the transition. The patient's vital signs are concerning: heart rate is persistently elevated at 130 beats per minute with irregular rhythm, respiratory rate is labored at 35 breaths per minute, and blood pressure remains critically low at 85/50 mmHg despite titration of norepinephrine. Physical examination reveals worsening peripheral cyanosis and cold extremities, indicative of poor perfusion. Auscultation of the lungs confirms diminished breath sounds bilaterally with crackles, suggestive of fluid accumulation and alveolar collapse.

A portable chest X-ray is performed immediately to assess for potential complications such as pneumothorax or worsening pulmonary edema. The results reveal diffuse bilateral infiltrates consistent with the progression of acute respiratory distress syndrome (ARDS) and a small pleural effusion on the right side. Additionally, an echocardiogram is urgently obtained, revealing a severely reduced ejection fraction of 25%, suggesting a new onset of cardiomyopathy, likely stress-induced or septic in nature. This finding complicates the hemodynamic management and underscores the need for cautious fluid administration and vasopressor support.

Despite these challenges, the patient is successfully intubated and placed on a lung-protective ventilation strategy. However, within hours, her urine output decreases significantly to less than 10 mL/hour, raising concerns about acute kidney injury (AKI) secondary to ongoing shock and multiple organ dysfunction. The interdisciplinary team quickly reconvenes to discuss the initiation of continuous renal replacement therapy (CRRT) to manage fluid overload and support renal function. This decision is weighed carefully against the backdrop of her fragile cardiovascular status, ensuring that the intervention will not further destabilize her condition. The team remains vigilant, prepared to adapt their strategy as new complications arise, understanding the critical balance required to steer her towards stabilization and recovery.